Search results for "Hepatitis B viru"

showing 10 items of 296 documents

Booster vaccination after neonatal priming with acellular pertussis vaccine.

2010

After a birth dose of acellular pertussis (aP) and diphtheria (DT)aP-hepatitis B virus (HBV)-inactivated polio vaccine (IPV)/ Haemophilus influenza type b (Hib) at 2, 4, and 6 months, a booster dose of DTaP-HBV-IPV/Hib at 12 to 23 months induced strong anti-pertussis booster responses. Thus, neonatal aP priming did not lead to immune tolerance to pertussis antigens. However, it elicited bystander interference on HBV, Hib, and diphtheria responses.

Whooping CoughFilamentous haemagglutinin adhesinImmunization SecondaryBooster dosemedicine.disease_causecomplex mixturesVirusPolio vaccineVaccines AcellularmedicineHumansWhooping coughHepatitis B virusPertussis VaccineDose-Response Relationship Drugbusiness.industryDiphtheriaVaccinationInfant Newbornvirus diseasesInfantmedicine.diseasePrognosisVirologyVaccinationPediatrics Perinatology and Child HealthImmunologybusinessFollow-Up StudiesThe Journal of pediatrics
researchProduct

RNA dependent DNA polymerase in cells of xeroderma pigmentosum

1971

Abstract Cells from X.P. ∗ skin contain an RNA dependent DNA polymerase, while in cells from normal skin this enzyme is lacking. This finding stimulates the thought that carcinogenesis in X.P. cells is due to an infection with an oncogenic RNA virus.

Xeroderma pigmentosumHepatitis B virus DNA polymeraseDNA polymeraseDNA polymerase IIDeoxyribonucleotidesPolynucleotidesBiophysicsRNA-dependent RNA polymeraseTritiummedicine.disease_causeRauscher VirusBiochemistryMicemedicineAnimalsChemical PrecipitationHumansMolecular BiologySkinchemistry.chemical_classificationXeroderma Pigmentosumintegumentary systembiologyRNA virusDNATemplates GeneticCell BiologyRibonucleotidesmedicine.diseasebiology.organism_classificationVirologyMolecular biologyStimulation ChemicalEnzymechemistryAmmonium SulfateDNA Nucleotidyltransferasesbiology.proteinRNAFemaleGuanosine TriphosphateCarcinogenesisBiochemical and Biophysical Research Communications
researchProduct

Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis.

2006

To the Editor: Tang et al.1 recently reported that lamivudine (LAM) improves renal outcome in patients with chronic hepatitis B virus (HBV) infection and membranous nephropathy. We would like to add our experience on acute hepatitis B and rapidly progressive glomerulonephritis.

business.industryvirus diseasesLamivudinemedicine.diseasedigestive system diseasesVirusMembranous nephropathyChronic hepatitisNephrologyHepatitis B virus | Glomerulonephritis | membranous nephropathyImmunologymedicineRapidly progressive glomerulonephritisIn patientAcute hepatitis Bbusinessmedicine.drug
researchProduct

Bleomycin, a selective inhibitor of DNA-dependent DNA polymerase from oncogenic RNA viruses.

1972

Abstract Bleomycin, an antibiotic, inhibits the DNA-dependent DNA polymerase from Rauscher murine leukemia virus. Higher concentrations of BLM ∗ are required to inhibit it's RNA-dependent DNA polymerase. These inhibition effects of the non-competitive type are not altered by preincubation of the DNA with BLM. Under comparable conditions neither the DNA-dependent DNA polymerase activity from E. coli and mouse liver nor the DNA-dependent RNA polymerase activity from mouse lymphoma cells are affected by BLM.

congenital hereditary and neonatal diseases and abnormalitiesTime FactorsLymphomaDNA polymeraseHepatitis B virus DNA polymeraseUracil NucleotidesDNA polymerase IIBiophysicsRNA-dependent RNA polymeraseCytosine NucleotidesTritiumBiochemistryRauscher VirusCell LineBleomycinMiceEscherichia coliAnimalsMolecular BiologyPolymeraseDNA clampAntibiotics Antineoplasticbiologyurogenital systemnutritional and metabolic diseasesCell BiologyDNAMolecular biologyReverse transcriptaseKineticsReal-time polymerase chain reactionLiverDNA Nucleotidyltransferasesbiology.proteinRNABiochemical and biophysical research communications
researchProduct

Risk of Virus Contamination Through Surgical Smoke During Minimally Invasive Surgery: A Systematic Review of the Literature on a Neglected Issue Revi…

2020

Abstract Context The coronavirus disease 2019 (COVID-19) pandemic raised concerns about the safety of laparoscopy due to the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diffusion in surgical smoke. Although no case of SARS-CoV-2 contagion related to surgical smoke has been reported, several international surgical societies recommended caution or even discouraged the use of a laparoscopic approach. Objective To evaluate the risk of virus spread due to surgical smoke during surgical procedures. Evidence acquisition We searched PubMed and Scopus for eligible studies, including clinical and preclinical studies assessing the presence of any virus in the surgical smoke fr…

covid-19; minimally invasive surgery; smoke; surgical; virus; covid-19; colectomy; condylomata acuminata; coronavirus infections; gastrectomy; hepatectomy; humans; laryngeal neoplasms; minimally invasive surgical procedures; pandemics; papilloma; papillomavirus infections; pneumonia; viral; risk; sars-cov-2; warts; betacoronavirus; hepatitis b virus; infectious disease transmission; patient-to-professional; laparoscopy; papillomaviridae; smokehepatitis b virusvirusesmedicine.medical_treatmentlaparoscopy030232 urology & nephrologyDiseasemedicine.disease_causeCOVID-19; Minimally invasive surgery; Surgical; Virus; smoke.Genital warts0302 clinical medicineSurgicalwartsPandemichumansriskColectomyCoronaviruscondylomata acuminataCOVID-19 Minimally invasive surgery smoke Surgical Virus Colectomy Condylomata Acuminata Coronavirus Infections Gastrectomy Hepatectomy Humans Laryngeal Neoplasms Minimally Invasive Surgical Procedures Pandemics Papilloma Papillomavirus Infections Pneumonia Viral Risk Warts Betacoronavirus Hepatitis B virus Infectious Disease Transmission Patient-to-Professional Laparoscopy Papillomaviridae SmokeTransmission (medicine)virus diseasescolectomyCOVID-19; Minimally invasive surgery; smoke; Surgical; VirusgastrectomyViruspapillomasars-cov-2030220 oncology & carcinogenesispatient-to-professionalpapillomavirus infectionsviralmedicine.medical_specialtyInfectious Disease Transmission Patient-to-Professionallaryngeal neoplasmsUrologyPneumonia ViralContext (language use)pandemicsArticle03 medical and health sciencescoronavirus infectionshepatectomyMinimally invasive surgerymedicinepneumoniaIntensive care medicinepapillomaviridaebusiness.industryCOVID-19infectious disease transmissionmedicine.diseasebetacoronavirusminimally invasive surgical proceduresPneumoniasmokebusinessEuropean Urology Focus
researchProduct

Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo.

2000

Abstract Background and aim. Research on hepatitis B virus (HBV) infection in vivo has been limited due to the absence of a suitable animal model. We have developed a human–mouse radiation chimera in which normal mice, preconditioned by lethal total body irradiation and radioprotected with SCID mouse bone marrow cells, are permissive for engraftment of human hematopoietic cells and solid tissues. This resulting human–mouse model, which comprises three genetically disparate sources of tissue, is therefore termed Trimera. This study was aimed at assessing the effect of human IL-6 on HBV infection in vivo in Trimera mice. Methods. Trimera mice were transplanted with human liver tissue fragment…

endocrine systemHepatitis B virusMice SCIDmedicine.disease_causeVirus ReplicationMiceIn vivoVirologymedicineAnimalsHumansHepatitis B virusbiologychimeric miceInterleukin-6Hepatitis BVirologyMolecular biologydigestive system diseasesIn vitroTransplantationDisease Models Animalmedicine.anatomical_structureCell cultureRadiation Chimerabiology.proteinviral infectionBone marrowAntibodyviral receptorEx vivoVirology
researchProduct

Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen i…

2012

hepatitis B virus therapy immunomodulator nucleos(t)ide analogues quantitative hepatitis B surface antigen
researchProduct

The affinities of monoclonal antibodies against core antigen of hepatitis B virus

1994

Four monoclonal antibodies generated against the recombinant core antigen of hepatitis B virus are investigated for antigen binding. All exhibit a similar affinity to polystyrene-sorbed antigen but only one of them interacts with native form of HBcAg (an assembled particle) in solution. The presence of 0.1% sodium dodecylsulphate is required for the binding of other three antibodies. The phenomenon can be interpreted as inaccessibility of the corresponding epitopes unless the multimeric antigen structure is disrupted. The core antigen coated on polystyrene is considered as a similar exposed structure.

medicine.drug_classAntibody AffinityBiologyAntibodies Viralmedicine.disease_causeMonoclonal antibodyEpitopeEpitopesMiceAntigenVirologymedicineAnimalsHepatitis B virusHybridomasT-cell receptorAntibodies MonoclonalSodium Dodecyl SulfateGeneral Medicinebiology.organism_classificationHepatitis B Core AntigensVirologyMolecular biologyRecombinant ProteinsHBcAgHepadnaviridaebiology.proteinAntibodyArchives of Virology
researchProduct

Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?

2017

Background In the absence of liver biopsy, the World Health Organization recommends non-invasive tests, such as aspartate aminotransferase to platelet ratio index and FIB-4, to assess liver fibrosis in patients with chronic hepatitis B. However, these tests are not well validated in sub-Saharan Africa. Recently, a new marker, gamma-glutamyl transpeptidase to platelet ratio, was found to be more accurate in an African setting, but this needs confirmation in other cohorts. Methods A treatment program for chronic hepatitis B was initiated in Addis Ababa, Ethiopia, in 2015. Non-invasive tests were compared with transient elastography (Fibroscan 402, Echosense, France) using the following thresh…

medicine.medical_specialtyCirrhosisViral Hepatitismedicine.disease_causeGastroenterology03 medical and health sciences0302 clinical medicineFibrosisInternal medicinemedicineGamma-glutamyltransferaseliver fibrosisHepatitis B virusHepatologyReceiver operating characteristicmedicine.diagnostic_testbiologybusiness.industrynon‐invasive testsmedicine.disease030220 oncology & carcinogenesisLiver biopsyPredictive value of testsbiology.proteinOriginal Article030211 gastroenterology & hepatologybusinessTransient elastographyhepatitis B virussub‐Saharan AfricaLiver International
researchProduct

Hepatitis B virus in diabetic patients

1980

The presence of HBV markers was determined in 149 serum samples obtained from diabetic patients and was compared with a normal population. Diabetics have the same incidence of HBsAg but significantly higher anti-HBc antibodies. These differences were seen in the group of diabetics on oral hypoglycemic therapy. These results cannot yet be explained.

medicine.medical_specialtyHBsAgEndocrinology Diabetes and MetabolismHbv markersAntibodies Viralmedicine.disease_causeGastroenterologyHepatitis B AntigensEndocrinologyInternal medicineDiabetes mellitusEpidemiologyDiabetes MellitusInternal MedicinemedicineHumansHepatitis B AntibodiesHepatitis B virusbiologybusiness.industryIncidence (epidemiology)virus diseasesGeneral MedicineSerum samplesmedicine.diseasedigestive system diseasesImmunologybiology.proteinAntibodybusinessActa Diabetologica Latina
researchProduct